1. J. R. Idle and R. L. Smith, Polymorphisms of Carbon Centers of Drugs and Their Clinical Significance, Drug Metabol. Rev., 9: 301–317 (1979).
2. E. S. Vesell, Pharmacogenetics, Biochem. Pharmacol., 24: 445–450 (1975).
3. O. Pelkonen, E. Sotaniemi, and R. Mokka, The In vitro Oxidative Metabolism of Benzo(a)pyrene in Human Liver Measured by Different Assays, Chem. Biol. Interactions, 16: 13–21 (1977).
4. N. Sabadie, C. Malaveille, A. M. Campus, and H. Bartsch, Com¬parison of the Hydroxylation of Benzo(a)pyrene with the Metabolism of Vinyl Chloride, N-Nitrosomorphine and N-Nitroso-N’- Methylpiperazine to Mutagens by Human and Rat Liver Microsomal Fractions, Cancer Res., 40: 119–26 (1980).
5. M. W. Kahng, M. W. Smith, and B. F. Trump, Aryl Hydrocarbon Hydroxylase in Human Bronchial Epithelium and Blood Monocyte, J. Natl. Cancer Inst., 66: 222–232 (1981).